MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AMRX — Amneal Pharmaceuticals, Inc. Class A Common Stock
NasdaqAmneal Pharmaceuticals, Inc. Class A Common Stock
$20.30
+0.23(+1.15%)
- O
- 20.19
- H
- 20.54
- L
- 20.00
- V
- 2.25M
⏱️ End-of-day dataAs of Oct 2, 2026
AMRX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $19.77M | $28.20M | $20.12M | $71.54M | $59.19M | $11.06M |
| Accounts Receivable | $85.09M | $89.51M | $88.52M | $80.76M | $75.42M | $77.57M |
| Other Receivables | $31.28M | $25.60M | $21.87M | $22.44M | $25.84M | $15.52M |
| Inventory | $64.16M | $60.63M | $61.45M | $60.90M | $60.14M | $61.25M |
| Prepaid Assets | $51.81M | $54.13M | $63.87M | $45.27M | $42.95M | $48.37M |
| Restricted Cash | $4.17M | $28.84M | $34.73M | $9.64M | $6.58M | $7.87M |
| Total Current Assets | $179.79M | $191.12M | $183.85M | $158.47M | $151.04M | $158.78M |
| Properties | $55.88M | $10.74M | $53.81M | $54.63M | $52.27M | $98.78M |
| Goodwill | $172.25M | $175.44M | $177.98M | $184.44M | $188.41M | $192.72M |
| Financial Assets | $10.15M | $5.76M | $5.17M | $16.44M | $23.77M | $35.92M |
| Intangible Assets | $53.49M | $56.35M | $58.79M | $64.95M | $68.91M | $73.24M |
| Other Non Current Assets | $12.72M | $14.50M | $17.38M | $12.13M | $6.90M | $8.10M |
| Total Non Current Assets | $174.23M | $176.71M | $176.14M | $183.81M | $185.48M | $191.36M |
| Total Assets | $354.02M | $367.83M | $359.99M | $342.28M | $336.52M | $350.14M |
| Accounts Payable | $22.77M | $25.47M | $26.64M | $20.58M | $19.25M | $25.87M |
| Accrued Expenses | $38.10M | $42.68M | $39.13M | $39.38M | $38.42M | $39.36M |
| Short Term Debt | $21.48M | $21.58M | $21.47M | $33.54M | $33.75M | $34.03M |
| Pensions | $54.27M | $79.89M | $63.90M | $57.01M | $41.60M | $72.96M |
| Other Current Liabilities | $10.55M | $43.26M | $40.60M | $41.52M | $43.50M | $31.75M |
| Total Current Liabilities | $72.80M | $88.16M | $86.21M | $110.71M | $107.58M | $112.98M |
| Long Term Debt | $267.50M | $266.75M | $266.43M | $224.65M | $224.20M | $225.29M |
| Provision For Risks And Charges | 0.00 | 0.00 | 216,000.00 | 524,000.00 | 549,000.00 | $1.25M |
| Other Non Current Liabilities | $71.25M | $92.73M | $88.53M | $82.67M | $80.09M | $94.05M |
| Total Non Current Liabilities | $285.81M | $286.80M | $284.77M | $242.82M | $234.88M | $248.12M |
| Total Liabilities | $358.62M | $374.96M | $370.98M | $353.53M | $342.46M | $361.10M |
| Common Stock | $3.19M | $3.15M | $3.14M | $3.14M | $3.13M | $3.10M |
| Retained Earnings | $-47.27M | $-53.50M | $-57.01M | $-57.24M | $-59.49M | $-60.71M |
| Other Shareholders Equity | $-11.22M | $-11.07M | $-10.59M | $-97.43M | $-85.74M | $-65.51M |
| Total Shareholders Equity | $-45.97M | $-71.33M | $-11.00M | $-11.25M | $-59.39M | $-10.95M |
| Additional Paid In Capital | $53.63M | $57.18M | $56.34M | $55.46M | $54.58M | $56.02M |
| Minority Interest | -558,000.00 | -535,000.00 | -497,000.00 | -415,000.00 | $72.28M | -245,000.00 |
| Land And Improvements | N/A | $19.69M | N/A | N/A | N/A | $8.11M |
| Machinery Furniture Equipment | N/A | $56.81M | N/A | N/A | N/A | $54.66M |
| Construction In Progress | N/A | $92.91M | N/A | N/A | N/A | $78.20M |
| Leases | N/A | $13.38M | N/A | N/A | N/A | $13.09M |
| Accumulated Depreciation | N/A | $-60.62M | N/A | N/A | N/A | $-56.35M |